# Polypharmacy in Clozapine-resistant Schizophrenia

> **NCT00918021** · PHASE4 · COMPLETED · sponsor: **Niuvanniemi Hospital** · enrollment: 30 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** olanzapine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00918021
- **Lead sponsor:** Niuvanniemi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2010-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00918021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00918021, "Polypharmacy in Clozapine-resistant Schizophrenia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00918021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*